Home Tools
Log in
Cart

Search Result

Search Results for " development "

20

Compounds

Cat No. Product Name Synonyms Targets
T9615 CK7 CDK
CK7, a Cdk2/9 inhibitor, is instrumental in the synthesis of Nek1 inhibitors BSc5231 and BSc5367.
TN3131 5-O-Cinnamoylquinic acid Others
5-O-Cinnamoylquinic acid is a nature product.
T9681 MAK-683 hydrochloride Histone Methyltransferase
MAK683 hydrochloride is an inhibitor of embryonic ectoderm development (EED). MAK683 exhibits IC50s of 59, 26, 89 nM in EED Alphascreen binding, ELISA and LC-MS assay.
T0508 γ-Aminobutyric acid Gamma-aminobutyric acid,4-Aminobutyric acid,GABA,4-Aminobutanoic acid,Piperidic acid GABA Receptor , Endogenous Metabolite
γ-Aminobutyric acid (4-Aminobutyric acid) is the most common inhibitory neurotransmitter in the central nervous system.
T4584 BMS-813160 BMS 813160 CCR
BMS-813160 is the first dual CCR2/CCR5 antagonist to enter Clinical development for cardiovascular.
T27320 Finrozole MPV 2213ad,MPV-2213ad,MPV 2213,MPV-2213,MPV2213ad Aromatase
Finrozole (MPV 2213ad) is a novel selective aromatase inhibitor that is partially reversible for breast development.
T14369 AZD-0284 ROR
AZD-0284 is an inverse agonist of the nuclear receptor RORγ. In development for the treatment of plaque psoriasis vulgaris and respiratory tract disorders[1].
T13911 Tacalcitol monohydrate Curatoderm monohydrate,TV 02 monohydrate,TV-02H monohydrate,1,24(R)-Dihydroxyvitamin D3 monohydrate Cysteine Protease
Tacalcitol monohydrate(Curatoderm monohydrate), a vitamin D3 analog that promotes bone development by regulating calcium ions, can be used to study psoriasis.
T27267 ENMD-1068 HCl ENMD-1068 HCl,ENMD 1068,ENMD-1068,ENMD1068,ENMD-1068 hydrochloride Protease-activated Receptor
ENMD-1068 HCl (ENMD 1068) is a PAR-2 antagonist. ENMD-1068 HCl inhibits the development of endometriosis in a mouse model.
T15561 Imanixil HOE-402(free base) Others
Imanixil is an inducer of the LDL receptor (LDLR) and it is also a potent cholesterol-lowering compound. It also inhibits very low density-lipoprotein (VLDL) production and consequently decreases atherosclerosis developm...
T11339L Furegrelate PPAR
FUREGRELATE, a thromboxane A2 (TxA2) synthase inhibitor, blunts the development of pulmonary arterial hypertension in neonatal piglets.
T5901 3-Hydroxy-2-methylpyridine Others
3-Hydroxy-2-methylpyridine could as a promising molecular scaffold for the future development of novel fibrillization inhibitors.
T7459 Abametapir HA-44,BRN 0123183 MMP , Others , Parasite
Abametapir (BRN 0123183), a metalloproteinase inhibitor, is able to target metalloproteinases critical to egg hatching and louse development.
T4844 L-Methionine L(-)-Methionin,L-Methionin Endogenous Metabolite
L-Methionine (L-Methionin) is the L-isomer of Methionine. Methionine is an essential amino acid for human development and acts as a hepatoprotectant.
T26712 AZD-1656 AZD 1656 Glucokinase
AZD-1656 is a glucokinase activator (GKA) that can cause dose-limiting hypoglycemia in normal animals used in embryofetal development studies and type 2 diabetes.
TN1296 5-Feruloylquinic acid 5-O-Feruloylquinic acid,5-FQA Tyrosinase , Sirtuin
5-Feruloylquinic acid (5-FQA) is a potent Sirt1 agonist, it is a potential lead compound that can be further tested in drug development process for diseases associated with aging.
TP2266L LF 11 acetate LF 11 acetate(832729-13-2 Free base) Antibacterial
LF 11 acetate exhibits antibacterial activities and can be used for the development of endotoxin-neutralizing and antibacterial agents.
T3523 Fostemsavir BMS-663068 HIV Protease
Fostemsavir (BMS-663068) is an HIV-1 attachment inhibitor in development for the treatment of HIV-1 infection.
T9924 Obinutuzumab Obinutuzumab/afutuzumab Others
Obinutuzumab (Obinutuzumab/afutuzumab) GA101) is a glycoengineered Type II CD20 monoclonal antibody in development for non-Hodgkin lymphoma.
TN1074 GL3 Others
GL3 encodes a bHLH protein that regulates trichome development in arabidopsis through interaction with GL1 and TTG1.

Compounds

CK7
T9615
Synonym:
Target: CDK
5-O-Cinnamoylquinic acid
TN3131
Synonym:
Target: Others
MAK-683 hydrochloride
T9681
Synonym:
Target: Histone Methyltransferase
γ-Aminobutyric acid
T0508
Synonym: Gamma-aminobutyric acid,4-Aminobutyric acid,GABA,4-Aminobutanoic acid,Piperidic acid
Target: GABA Receptor, Endogenous Metabolite
BMS-813160
T4584
Synonym: BMS 813160
Target: CCR
Finrozole
T27320
Synonym: MPV 2213ad,MPV-2213ad,MPV 2213,MPV-2213,MPV2213ad
Target: Aromatase
AZD-0284
T14369
Synonym:
Target: ROR
Tacalcitol monohydrate
T13911
Synonym: Curatoderm monohydrate,TV 02 monohydrate,TV-02H monohydrate,1,24(R)-Dihydroxyvitamin D3 monohydrate
Target: Cysteine Protease
ENMD-1068 HCl
T27267
Synonym: ENMD-1068 HCl,ENMD 1068,ENMD-1068,ENMD1068,ENMD-1068 hydrochloride
Target: Protease-activated Receptor
Imanixil
T15561
Synonym: HOE-402(free base)
Target: Others
Furegrelate
T11339L
Synonym:
Target: PPAR
3-Hydroxy-2-methylpyridine
T5901
Synonym:
Target: Others
Abametapir
T7459
Synonym: HA-44,BRN 0123183
Target: MMP, Others, Parasite
L-Methionine
T4844
Synonym: L(-)-Methionin,L-Methionin
Target: Endogenous Metabolite
AZD-1656
T26712
Synonym: AZD 1656
Target: Glucokinase
5-Feruloylquinic acid
TN1296
Synonym: 5-O-Feruloylquinic acid,5-FQA
Target: Tyrosinase, Sirtuin
LF 11 acetate
TP2266L
Synonym: LF 11 acetate(832729-13-2 Free base)
Target: Antibacterial
Fostemsavir
T3523
Synonym: BMS-663068
Target: HIV Protease
Obinutuzumab
T9924
Synonym: Obinutuzumab/afutuzumab
Target: Others
GL3
TN1074
Synonym:
Target: Others
1 2 3 4 5 ... 30
TargetMol